Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case–control study

Breast Cancer Research and Treatment

Volumn 159, Issue 1, 2016, Pages 163-172

  Figueroa, Jonine D ^a,b   Pfeiffer, Ruth M ^a   Brinton, Louise A ^a   Palakal, Maya M ^a   Degnim, Amy C ^c   Radisky, Derek ^c   Hartmann, Lynn C ^c   Frost, Marlene H ^c   Stallings Mann, Melody L ^c   Papathomas, Daphne ^a   Gierach, Gretchen L ^a   Hewitt, Stephen M ^a   Duggan, Maire A ^d   Visscher, Daniel ^c   Sherman, Mark E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c MAYO CLINIC CANCER CENTER   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

Breast cancer risk; Lobular involution

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; BREAST CANCER; BREAST DISEASE; BREAST EXAMINATION; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; TERMINAL DUCT LOBULAR UNIT; TERMINAL DUCT LOBULAR UNIT ACINI; TERMINAL DUCT LOBULAR UNIT COUNT; TERMINAL DUCT LOBULAR UNIT SPAN; BIOPSY; BREAST; BREAST TUMOR; COMPLICATION; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; FIBROCYSTIC BREAST DISEASE; MIDDLE AGED; PATHOLOGY;

BIOPSY; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT;

EID: 84982839188     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-016-3908-7     Document Type: Article

References (34)

1. Allison KH, Abraham LA, Weaver DL, Tosteson AN, Nelson HD, Onega T, Geller BM, Kerlikowske K, Carney PA, Ichikawa LE, Buist DS, Elmore JG (2015) Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium. Cancer. doi:10.1002/cncr.29199
2. Dyrstad SW, Yan Y, Fowler AM, Colditz GA (2015) Breast cancer risk associated with benign breast disease: systematic review and meta-analysis. Breast Cancer Res Treat 149(3):569–575. doi:10.1007/s10549-014-3254-6
3. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81(24):1879–1886
4. Pankratz VS, Degnim AC, Frank RD, Frost MH, Visscher DW, Vierkant RA, Hieken TJ, Ghosh K, Tarabishy Y, Vachon CM, Radisky DC, Hartmann LC (2015) Model for individualized prediction of breast cancer risk after a benign breast biopsy. J Clin Oncol. doi:10.1200/JCO.2014.55.4865
5. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan B, Nygren P, Humphrey L (2009) Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 151(10):727–737. doi:10.7326/0003-4819-151-10-200911170-00009
6. Cummings SR, Tice JA, Bauer S, Browner WS, Cuzick J, Ziv E, Vogel V, Shepherd J, Vachon C, Smith-Bindman R, Kerlikowske K (2009) Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst 101(6):384–398. doi:10.1093/jnci/djp018
7. Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, Pankratz VS, Degnim AC, Vachon CM, Reynolds CA, Thompson RA, Melton LJ 3rd, Goode EL, Visscher DW (2006) Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 98(22):1600–1607. doi:10.1093/jnci/djj439
8. Baer HJ, Collins LC, Connolly JL, Colditz GA, Schnitt SJ, Tamimi RM (2009) Lobule type and subsequent breast cancer risk: results from the Nurses’ Health Studies. Cancer 115(7):1404–1411. doi:10.1002/cncr.24167
9. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ 3rd, Visscher DW (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353(3):229–237.
10. Wellings SR, Jensen HM (1973) On the origin and progression of ductal carcinoma in the human breast. J Natl Cancer Inst 50(5):1111–1118
11. Figueroa JD, Pfeiffer RM, Patel DA, Linville L, Brinton LA, Gierach GL, Yang XR, Papathomas D, Visscher D, Mies C, Degnim AC, Anderson WF, Hewitt S, Khodr ZG, Clare SE, Storniolo AM, Sherman ME (2014) Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology. J Natl Cancer Inst. doi:10.1093/jnci/dju286
12. Ginsburg OM, Martin LJ, Boyd NF (2008) Mammographic density, lobular involution, and risk of breast cancer. Br J Cancer 99(9):1369–1374. doi:10.1038/sj.bjc.6604635
13. Henson DE, Tarone RE (1994) Involution and the etiology of breast cancer. Cancer 74(1):424–429
14. Jensen HM (1986) On the origin and progression of human breast cancer. Am J Obstet Gynecol 154(6):1280–1284. doi:10.1016/0002-9378(86)90713-1
15. McKian KP, Reynolds CA, Visscher DW, Nassar A, Radisky DC, Vierkant RA, Degnim AC, Boughey JC, Ghosh K, Anderson SS, Minot D, Caudill JL, Vachon CM, Frost MH, Pankratz VS, Hartmann LC (2009) Novel breast tissue feature strongly associated with risk of breast cancer. J Clin Oncol 27(35):5893–5898. doi:10.1200/jco.2008.21.5079
16. Horne HNSM, Pfeiffer RM, Figueroa JD, Khodr Z, Falk RT, Pollak M, Patel DA, Linville L, Papathomas D, Geller B, Vacek PM, Weaver DL, Chicoine R, Shepherd J, Mahmoudzadeh AP, Wang J, Fan B, Herschorn S, Hewitt SM, Brinton LA, Gierach GL (2016) Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast. Cancer Res. doi:10.1186/s13058-016-0678-4
17. Khodr ZG, Sherman ME, Pfeiffer RM, Gierach GL, Brinton LA, Falk RT, Patel DA, Linville LM, Papathomas D, Clare SE, Visscher DW, Mies C, Hewitt SM, Storniolo AM, Rosebrock A, Caban JJ, Figueroa JD (2014) Circulating sex hormones and terminal duct lobular unit involution of the normal breast. Cancer Epidemiol Biomarkers Prev 23(12):2765–2773. doi:10.1158/1055-9965
18. Gierach GL, Patel DA, Pfeiffer RM, Figueroa JD, Linville L, Papathomas D, Johnson JM, Chicoine RE, Herschorn SD, Shepherd JA, Wang J, Malkov S, Vacek PM, Weaver DL, Fan B, Mahmoudzadeh AP, Palakal M, Xiang J, Oh H, Horne HN, Sprague BL, Hewitt SM, Brinton LA, Sherman ME (2016) Relationship of terminal duct lobular unit involution of the breast with area and volume mammographic densities. Cancer prevention research 9(2):149–158. doi:10.1158/1940-6207
19. Horne HN, Sherman ME, Pfeiffer RM, Figueroa JD, Khodr ZG, Falk RT, Pollak M, Patel DA, Palakal MM, Linville L, Papathomas D, Geller B, Vacek PM, Weaver DL, Chicoine R, Shepherd J, Mahmoudzadeh AP, Wang J, Fan B, Malkov S, Herschorn S, Hewitt SM, Brinton LA, Gierach GL (2016) Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease. Breast Cancer Res 18(1):24. doi:10.1186/s13058-016-0678-4
20. Oh H, Khodr ZG, Sherman ME, Palakal M, Pfeiffer RM, Linville L, Geller BM, Vacek PM, Weaver DL, Chicoine RE, Falk RT, Horne HN, Papathomas D, Patel DA, Xiang J, Xu X, Veenstra T, Hewitt SM, Shepherd JA, Brinton LA, Figueroa JD, Gierach GL (2016) Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy. Horm Cancer. doi:10.1007/s12672-016-0265-2
21. Hutson SW, Cowen PN, Bird CC (1985) Morphometric studies of age related changes in normal human breast and their significance for evolution of mammary cancer. J Clin Pathol 38(3):281–287
22. Vierkant RA, Hartmann LC, Pankratz VS, Anderson SS, Radisky D, Frost MH, Vachon CM, Ghosh K, Distad TJ, Degnim AC, Reynolds CA (2009) Lobular involution: localized phenomenon or field effect? Breast Cancer Res Treat 117(1):193–196. doi:10.1007/s10549-008-0082-6
23. Yang XR, Figueroa JD, Falk RT, Zhang H, Pfeiffer RM, Hewitt SM, Lissowska J, Peplonska B, Brinton L, Garcia-Closas M, Sherman ME (2012) Analysis of Terminal Duct Lobular Unit (TDLU) Involution in Luminal A and Basal Breast Cancers. Breast Cancer Res 14(2):R64. doi:10.1186/bcr3170
24. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG (1983) ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer. Nature 303(5920):767–770
25. Ghosh K, Hartmann LC, Reynolds C, Visscher DW, Brandt KR, Vierkant RA, Scott CG, Radisky DC, Sellers TA, Pankratz VS, Vachon CM (2010) Association between mammographic density and age-related lobular involution of the breast. J Clin Oncol 28(13):2207–2212. doi:10.1200/jco.2009.23.4120
26. Ghosh K, Vachon CM, Pankratz VS, Vierkant RA, Anderson SS, Brandt KR, Visscher DW, Reynolds C, Frost MH, Hartmann LC (2010) Independent association of lobular involution and mammographic breast density with breast cancer risk. J Natl Cancer Inst 102(22):1716–1723. doi:10.1093/jnci/djq414
27. Gierach GL, Brinton LA, Sherman ME (2010) Lobular involution, mammographic density, and breast cancer risk: visualizing the future? J Natl Cancer Inst 102(22):1685–1687. doi:10.1093/jnci/djq433
28. Rice MS, Tamimi RM, Connolly JL, Collins LC, Shen D, Pollak MN, Rosner B, Hankinson SE, Tworoger SS (2012) Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses’ Health Study II. Breast Cancer Res 14(2):R44. doi:10.1186/bcr3141
29. Russo J, Balogh G, Russo IH (2007) Breast cancer prevention. Climacteric 10(Suppl 2):47–53. doi:10.1080/13697130701606762
30. Rotunno M, Sun X, Figueroa J, Sherman ME, Garcia-Closas M, Meltzer P, Williams T, Schneider SS, Jerry DJ, Yang XR, Troester MA (2014) Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status. Breast Cancer Res 16(1):R74. doi:10.1186/bcr3689
31. Haricharan S, Li Y (2014) STAT signaling in mammary gland differentiation, cell survival and tumorigenesis. Mol Cell Endocrinol 382(1):560–569. doi:10.1016/j.mce.2013.03.014
32. Radisky DC, Hartmann LC (2009) Mammary involution and breast cancer risk: transgenic models and clinical studies. J Mammary Gland Biol Neoplasia 14(2):181–191. doi:10.1007/s10911-009-9123-y
33. Rosebrock A, Caban JJ, Figueroa J, Gierach G, Linville L, Hewitt S, Sherman M (2013) Quantitative Analysis of TDLUs using Adaptive Morphological Shape Techniques. Proc SPIE Int Soc Opt Eng. doi:10.1117/12.2006619
34. Sandhu R, Chollet-Hinton L, Kirk EL, Midkiff B, Troester MA (2016) Digital histologic analysis reveals morphometric patterns of age-related involution in breast epithelium and stroma. Hum Pathol 48:60–68. doi:10.1016/j.humpath.2015.09.031